Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Psychiatry Physician in Binghamton, NY
NPI: 1285735720Primary Practice Location
UNITED HEALTH SERVICES HOSPITALS, INC
10-42 Mitchell Ave, Binghamton, NY
HQ Phone
Get M.D. Cathy's Phone NumberMobile
Get M.D. Cathy's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
CA State Medical License
1985 - 2027
NY State Medical License
1987 - 2027
American Board of Psychiatry and Neurology
Psychiatry
Zucker School of Medicine at Hofstra/Northwell at Zucker Hillside Hospital
Residency • Psychiatry
1988 - 1990
Royal Prince Alfred Hospital
Registrar in Alcohol and Substance Abuse • Medicine
1986 - 1988
UCSF School of Medicine
medschool.ucsf.edu
Residency • Psychiatry
1984 - 1986
Jacobs School of Medicine and Biomedical Sciences
medicine.buffalo.edu
Medical School
Until 1984
Coprophenomena in Tourette syndrome.
Authors: Freeman, R. D., Zinner, S. H., Müller-Vahl, K. R., Fast, D. K., Burd, L. J., Kano, Y., Rothenberger, A., Roessner, V., Kerbeshian, J., Stern, J. S., Jankovic, J., Loughin, T., Janik, P., Shady, G., Robertson, M. M., Lang, A. E., Budman, C., Magor, A., Bru
Clinical phenomenology of episodic rage in children with Tourette syndrome.
Authors: Cathy L. Budman, Lori Rockmore, John M. Stokes, Mark Sossin
Publication Date: 2003-07
Identification of Two Heritable Cross-Disorder Endophenotypes for Tourette Syndrome.
Authors: Matthew Hirschtritt, Robert King, Gholson Lyon, Dongmei Yue, Carol Mathews, Jeremiah Scharf, Erica Greenberg, William Mcmahon, Marco Grados
Publication Date: 2016-11-04
Lead Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.
Collaborators: Nuvelution TS Pharma, Inc.
Intervention / Treatment: DRUG: Placebo, DRUG: TEV-50717
Lead Sponsor: Neurocrine Biosciences
Intervention / Treatment: DRUG: Placebo, DRUG: NBI-98854
Lead Sponsor: Synchroneuron Inc.
Intervention / Treatment: DRUG: SNC-102 sustained release tablet
